Specific immunotherapy using Hymenoptera venom: Systematic review;Imunoterapia específica com venenos de Hymenoptera: Revisão sistemática

Sao Paulo Medical Journal

Volumn 128, Issue 1, 2010, Pages 30-37

  Watanabe, Alexandra Sayuri ^a   Fonseca, Luiz Augusto Marcondes ^a   Galvão, Clóvis Eduardo Santos ^a   Kalil, Jorge ^a   Castro, Fabio Fernandes Morato ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hymenoptera; Immunotherapy; Insects; Meta analysis publication type ; Review publication type

Indexed keywords

HYMENOPTERA VENOM; PLACEBO;

CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE SEVERITY; FOLLOW UP; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; INSECT STING; META ANALYSIS; REVIEW; SKIN MANIFESTATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 77953793723     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802010000100007     Document Type: Review

References (30)

1. Helbling A, Hurni T, Mueller UR, Pitchler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy. 2004;34(2):285-90.
2. Golden DB, Marsh DG, Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA. 1989;262(2):240-4.
3. Golden DB. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol. 2005;115(3):439-47; quiz 448.
4. Incorvaia C, Pucci S, Pastorello EA. Clinical aspects of Hymenoptera venom allergy. Allergy. 1999;54 Suppl 58:50-2.
5. The discontinuation of Hymenoptera venom immunotherapy. Report from the Committee on Insects. J Allergy Clin Immunol. 1998;101(5):573-5.
6. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
7. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299(4):157-61.
8. Schuberth KC, Lichtenstein LM, Kagey-Sobotka A, Szklo M, Kwiterovich KA, Valentine MD. Epidemiologic study of insect allergy in children. II. Effect of accidental stings in allergic children. J Pediatr. 1983;102(3):361-5.
9. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med. 1990;323(23):1601-3.
10. Brown SG, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial. Lancet. 2003;361(9362):1001-6.
11. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis. Clin Ther. 2000;22(3):351-8.
12. Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med. 2004;351(7):668-74.
13. Blaauw PJ, Smithuis OL, Elbers AR. The value of an in-hospital insect sting challenge as a criterion for application or omission of venom immunotherapy. J Allergy Clin Immunol. 1996;98(1):39-47.
14. Kipper DJ, Saldanha MO, Tessaro L, Lança EA, Garcia PCR. Reações anafiláticas a picadas de formigas [Anaphylatic reactions to ant stings]. J Pediatr (Rio J) 1998;74(3):243-6.
15. Tracy JM, Demain JG, Quinn JM, Hoffman DR, Goetz DW, Freeman TM. The natural history of exposure to the imported fire ant (Solenopsis invicta). J Allergy Clin Immunol. 1995;95(4):824-8.
16. Rhoades RB, Stafford CT, James FK Jr. Survey of fatal anaphylactic reactions to imported fire ant stings. Report of the Fire Ant Subcommittee of the American Academy of Allergy and Immunology. J Allergy Clin Immunol. 1989;84(2):159-62.
17. Moffitt JE, Barker JR, Stafford CT. Management of imported fire ant allergy: results of a survey. Ann Allergy Asthma Immunol. 1997;79(2):125-30.
18. Hoffman DR, Jacobson RS, Schmidt M, Smith AM. Allergens in Hymenoptera venoms. XXIII. Venom content of imported fire ant whole body extracts. Ann Allergy. 1991;66(1): 29-31.
19. Freeman TM, Hylander R, Ortiz A, Martin ME. Imported fire ant immunotherapy: effectiveness of whole body extracts. J Allergy Clin Immunol. 1992;90(2):210-5.
20. Triplett RF. Sensitivity to the imported fire ant: successful treatment with immunotherapy. South Med J. 1973;66(4):477-80.
21. Tankersley MS, Walker RL, Butler WK, Hagan LL, Napoli DC, Freeman TM. Safety and efficacy of an imported fire ant rush immunotherapy protocol with and without prophylactic treatment. J Allergy Clin Immunol. 2002;109(3):556-62.
22. Lerch E, Müller UR. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol. 1998;101(5):606-12.
23. Lui CL, Heddle RJ, Kupa A, Coates T, Roberts-Thomson PJ. Bee venom hypersensitivity and its management: patients perception of venom desensitisation. Asian Pac J Allergy Immunol. 1995;13(2):95-100.
24. Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol. 1991;88(3 Pt 1):339-48.
25. Golden DB, Schwartz HJ. Guidelines for venom immunotherapy. J Allergy Clin Immunol. 1986;77(5):727-8.
26. Moffitt JE, Golden DB, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol. 2004;114(4):869-86.
27. Reisman RE. Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions. J Allergy Clin Immunol. 1992;90(3 Pt 1):335-9.
28. Charpin D, Birnbaum J, Vervloet D. Epidemiology of hymenoptera allergy. Clin Exp Allergy. 1994;24(11):1010-5.
29. Antonicelli L, Bilò MB, Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol. 2002;2(4):341-6.
30. Oude Elberink JN, De Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol. 2002;110(1):174-82.